Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Gross PP&E Adjustments: 2015-2020

Historic Other Gross PP&E Adjustments for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $703,769.

  • Outlook Therapeutics' Other Gross PP&E Adjustments fell 96.49% to $703,769 in Q2 2020 from the same period last year, while for Jun 2020 it was -$1.6 million, marking a year-over-year decrease of 101.90%. This contributed to the annual value of $808,221 for FY2019, which is 96.31% down from last year.
  • According to the latest figures from Q2 2020, Outlook Therapeutics' Other Gross PP&E Adjustments is $703,769, which was up 144.79% from -$1.6 million recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Other Gross PP&E Adjustments registered a high of $23.3 million during Q1 2018, and its lowest value of -$1.6 million during Q1 2020.
  • Its 3-year average for Other Gross PP&E Adjustments is $12.7 million, with a median of $20.0 million in 2019.
  • As far as peak fluctuations go, Outlook Therapeutics' Other Gross PP&E Adjustments increased by 19.94% in 2018, and later crashed by 107.90% in 2020.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Other Gross PP&E Adjustments stood at $19.4 million in 2016, then increased by 13.95% to $22.1 million in 2017, then fell by 7.29% to $20.5 million in 2018, then tumbled by 107.37% to -$1.5 million in 2019, then plummeted by 96.49% to $703,769 in 2020.
  • Its Other Gross PP&E Adjustments was $703,769 in Q2 2020, compared to -$1.6 million in Q1 2020 and -$1.5 million in Q4 2019.